vs
Steris（STE）与TRINET GROUP, INC.（TNET）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是TRINET GROUP, INC.的1.2倍（$1.5B vs $1.2B），Steris同比增速更快（9.2% vs -2.2%），Steris自由现金流更多（$199.5M vs $43.0M），过去两年Steris的营收复合增速更高（15.8% vs -0.6%）
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
TriNet Group, Inc.是一家面向中小企业的专业雇主组织，总部位于加州都柏林，服务员工规模在3至2500人之间的各类机构。可提供薪资管理、健康福利管理服务，还能为客户提供劳动法规合规、风险降低相关咨询，可作为外包人力资源部门为企业分担人事相关事务。
STE vs TNET — 直观对比
营收规模更大
STE
是对方的1.2倍
$1.2B
营收增速更快
STE
高出11.4%
-2.2%
自由现金流更多
STE
多$156.5M
$43.0M
两年增速更快
STE
近两年复合增速
-0.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.2B |
| 净利润 | $192.9M | — |
| 毛利率 | 43.8% | — |
| 营业利润率 | 18.3% | 0.1% |
| 净利率 | 12.9% | — |
| 营收同比 | 9.2% | -2.2% |
| 净利润同比 | 11.2% | — |
| 每股收益（稀释后） | $1.96 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STETNET
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.1B | $1.3B |
净利润STETNET
| Q4 25 | $192.9M | — | ||
| Q3 25 | $191.9M | $34.0M | ||
| Q2 25 | $177.4M | $37.0M | ||
| Q1 25 | $145.7M | $85.0M | ||
| Q4 24 | $173.5M | — | ||
| Q3 24 | $150.0M | $45.0M | ||
| Q2 24 | $145.4M | $60.0M | ||
| Q1 24 | $-1.4M | $91.0M |
毛利率STETNET
| Q4 25 | 43.8% | — | ||
| Q3 25 | 44.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 43.3% | — | ||
| Q4 24 | 44.5% | — | ||
| Q3 24 | 43.6% | — | ||
| Q2 24 | 44.7% | — | ||
| Q1 24 | 40.2% | — |
营业利润率STETNET
| Q4 25 | 18.3% | 0.1% | ||
| Q3 25 | 18.2% | 4.1% | ||
| Q2 25 | 17.7% | 4.1% | ||
| Q1 25 | 14.6% | 8.9% | ||
| Q4 24 | 17.9% | -2.9% | ||
| Q3 24 | 16.5% | 4.7% | ||
| Q2 24 | 14.5% | 6.5% | ||
| Q1 24 | 22.0% | 9.7% |
净利率STETNET
| Q4 25 | 12.9% | — | ||
| Q3 25 | 13.1% | 2.8% | ||
| Q2 25 | 12.8% | 3.0% | ||
| Q1 25 | 9.8% | 6.6% | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 11.3% | 3.6% | ||
| Q2 24 | 11.4% | 4.9% | ||
| Q1 24 | -0.1% | 7.2% |
每股收益（稀释后）STETNET
| Q4 25 | $1.96 | $0.02 | ||
| Q3 25 | $1.94 | $0.70 | ||
| Q2 25 | $1.79 | $0.77 | ||
| Q1 25 | $1.48 | $1.71 | ||
| Q4 24 | $1.75 | $-0.44 | ||
| Q3 24 | $1.51 | $0.89 | ||
| Q2 24 | $1.46 | $1.20 | ||
| Q1 24 | $-0.02 | $1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $287.0M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $7.2B | $54.0M |
| 总资产 | $10.6B | $3.8B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资STETNET
| Q4 25 | $423.7M | $287.0M | ||
| Q3 25 | $319.2M | $321.0M | ||
| Q2 25 | $279.7M | $407.0M | ||
| Q1 25 | $171.7M | $349.0M | ||
| Q4 24 | $155.2M | $360.0M | ||
| Q3 24 | $172.2M | $301.0M | ||
| Q2 24 | $198.3M | $249.0M | ||
| Q1 24 | $207.0M | $383.0M |
总债务STETNET
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $3.1B | — |
股东权益STETNET
| Q4 25 | $7.2B | $54.0M | ||
| Q3 25 | $7.0B | $110.0M | ||
| Q2 25 | $7.0B | $107.0M | ||
| Q1 25 | $6.6B | $63.0M | ||
| Q4 24 | $6.4B | $69.0M | ||
| Q3 24 | $6.6B | $129.0M | ||
| Q2 24 | $6.4B | $100.0M | ||
| Q1 24 | $6.3B | $143.0M |
总资产STETNET
| Q4 25 | $10.6B | $3.8B | ||
| Q3 25 | $10.4B | $3.4B | ||
| Q2 25 | $10.4B | $3.7B | ||
| Q1 25 | $10.1B | $3.8B | ||
| Q4 24 | $10.0B | $4.1B | ||
| Q3 24 | $10.2B | $3.7B | ||
| Q2 24 | $10.1B | $3.7B | ||
| Q1 24 | $11.1B | $4.0B |
负债/权益比STETNET
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $298.2M | $61.0M |
| 自由现金流经营现金流 - 资本支出 | $199.5M | $43.0M |
| 自由现金流率自由现金流/营收 | 13.3% | 3.4% |
| 资本支出强度资本支出/营收 | 6.6% | 1.4% |
| 现金转化率经营现金流/净利润 | 1.55× | — |
| 过去12个月自由现金流最近4个季度 | $917.1M | $234.0M |
8季度趋势，按日历期对齐
经营现金流STETNET
| Q4 25 | $298.2M | $61.0M | ||
| Q3 25 | $287.8M | $72.0M | ||
| Q2 25 | $420.0M | $75.0M | ||
| Q1 25 | $260.8M | $95.0M | ||
| Q4 24 | $332.8M | $65.0M | ||
| Q3 24 | $250.7M | $84.0M | ||
| Q2 24 | $303.7M | $39.0M | ||
| Q1 24 | $254.8M | $91.0M |
自由现金流STETNET
| Q4 25 | $199.5M | $43.0M | ||
| Q3 25 | $201.3M | $55.0M | ||
| Q2 25 | $326.4M | $57.0M | ||
| Q1 25 | $189.9M | $79.0M | ||
| Q4 24 | $243.6M | $47.0M | ||
| Q3 24 | $148.8M | $59.0M | ||
| Q2 24 | $195.7M | $22.0M | ||
| Q1 24 | $163.3M | $73.0M |
自由现金流率STETNET
| Q4 25 | 13.3% | 3.4% | ||
| Q3 25 | 13.8% | 4.5% | ||
| Q2 25 | 23.5% | 4.6% | ||
| Q1 25 | 12.8% | 6.1% | ||
| Q4 24 | 17.8% | 3.7% | ||
| Q3 24 | 11.2% | 4.8% | ||
| Q2 24 | 15.3% | 1.8% | ||
| Q1 24 | 14.6% | 5.8% |
资本支出强度STETNET
| Q4 25 | 6.6% | 1.4% | ||
| Q3 25 | 5.9% | 1.4% | ||
| Q2 25 | 6.7% | 1.5% | ||
| Q1 25 | 4.8% | 1.2% | ||
| Q4 24 | 6.5% | 1.4% | ||
| Q3 24 | 7.7% | 2.0% | ||
| Q2 24 | 8.4% | 1.4% | ||
| Q1 24 | 8.2% | 1.4% |
现金转化率STETNET
| Q4 25 | 1.55× | — | ||
| Q3 25 | 1.50× | 2.12× | ||
| Q2 25 | 2.37× | 2.03× | ||
| Q1 25 | 1.79× | 1.12× | ||
| Q4 24 | 1.92× | — | ||
| Q3 24 | 1.67× | 1.87× | ||
| Q2 24 | 2.09× | 0.65× | ||
| Q1 24 | — | 1.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
TNET
| Insurance Services | $1.1B | 85% |
| Professional Services | $169.0M | 14% |
